If you thought the FDA’s approval of Aduhelm for Alzheimer’s was controversial, you should hear the experts' thoughts on off-label use
When the FDA granted Biogen an accelerated approval for Biogen’s Aduhelm, it wasn’t just Alzheimer’s patients who got their hopes up.
There is, for instance …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
